Evidence map›Paper›PMID 33257958›Full record

ArticleEuropean heart journal2021

Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data.

Johanne Silvain, Michel Zeitouni, Valeria Paradies, Huili L Zheng, Gjin Ndrepepa, Claudio Cavallini, Dimitri N Feldman, Samin K Sharma, Julinda Mehilli, Sebastiano Gili and 9 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in European heart journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 120 citations in OpenAlex.

  1. Optical coherence tomography-guided percutaneous coronary intervention in acute coronary syndrome patients with complex lesions: a subgroup analysis of the randomised OCCUPI Trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Trial
  2. Trial
  3. Evolocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary intervention: the randomised, open-label EVOCATION trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2022
    Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Periprocedural Myocardial Infarction: Do We Need an Updated Definition?Journal of cardiovascular development and disease · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Review
  15. Review
  16. Review
  17. Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 17 institutions in 10 countries.

Johanne SilvainSorbonne Université, ACTION Study Group, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), INSERM UMRS 1166, 47-83 bld de l'Hôpital, 75013 Paris, France.
Michel ZeitouniSorbonne Université, ACTION Study Group, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), INSERM UMRS 1166, 47-83 bld de l'Hôpital, 75013 Paris, France.
Valeria ParadiesCardiology Department, Maasstad Hospital, Rotterdam, Netherlands.
Huili L ZhengHealth Promotion Board, National Registry of Diseases Office, Singapore, Singapore.
Gjin NdrepepaDepartment of Adult Cardiology, Deutsches Herzzentrum München, Technische Universität, Munich, Germany.
Claudio CavalliniDivision of Cardiology, Ospedale S Maria della Misericordia, Piazzale Meneghini 1, Perugia 06100, Italy.
Dimitri N FeldmanDivision of Cardiology, Weill Cornell Medical College, New York, NY, USA.
Samin K SharmaCardiac Catheterization Laboratory, Cardiovascular Institute, Mount Sinai Hospital, New York, NY, USA.
Julinda MehilliMunich University Clinic, Ludwig-Maximilians University, Munich, Germany.
Sebastiano GiliCentro Cardiologico Monzino, IRCCS, Milan, Italy.
Emanuele BarbatoDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Napoli, Italy.
Giuseppe TarantiniDepartment of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy.
Sze Y OoiEastern Heart Clinic, Prince of Wales Hospital, Sydney, NSW, Australia.
Clemens von BirgelenDepartment of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, Netherlands.
Allan S JaffeDepartment of Cardiology, Mayo Clinic, Rochester, MN, USA.
Kristian ThygesenDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Gilles MontalescotSorbonne Université, ACTION Study Group, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), INSERM UMRS 1166, 47-83 bld de l'Hôpital, 75013 Paris, France.
Heerajnarain BulluckDepartment of Cardiology, Norfolk and Norwich University Hospital, Norwich, UK.
Derek J HausenloyThe Hatter Cardiovascular Institute, University College London, London, UK.
Inserm · FRAarhus University Hospital · DKAsia University · TWCentro Cardiologico Monzino · ITCornell University · USDeutsches Herzzentrum München · DEGerman Centre for Cardiovascular Research · DEHealth Promotion Board · SGMaasstad Ziekenhuis · NLMayo Clinic in Arizona · USMedisch Spectrum Twente · NLMount Sinai Hospital · USNorfolk and Norwich University Hospital · GBOspedale Santa Maria · ITPrince of Wales Hospital · AUUniversity of Naples Federico II · ITUniversity of Padua · IT

Funding

British Heart Foundation CS/14/3/31002
6 · The paper itself

Abstract

aimsThe prognostic importance of cardiac procedural myocardial injury and myocardial infarction (MI) in chronic coronary syndrome (CCS) patients undergoing elective percutaneous coronary intervention (PCI) is still debated. METHODS AND

resultsWe analysed individual data of 9081 patients undergoing elective PCI with normal pre-PCI baseline cardiac troponin (cTn) levels. Multivariate models evaluated the association between post-PCI elevations in cTn and 1-year mortality, while an interval analysis evaluated the impact of the size of the myocardial injury on mortality. Our analysis was performed in the overall population and also according to the type of cTn used [52.0% had high-sensitivity cTn (hs-cTn)]. Procedural myocardial injury, as defined by the Fourth Universal Definition of MI (UDMI) [post-PCI cTn elevation ≥1 × 99th percentile upper reference limit (URL)], occurred in 52.8% of patients and was not associated with 1-year mortality [adj odds ratio (OR), 1.35, 95% confidence interval (CI) (0.84-1.77), P = 0.21]. The association between post-PCI cTn elevation and 1-year mortality was significant starting ≥3 × 99th percentile URL. Major myocardial injury defined by post-PCI ≥5 × 99th percentile URL occurred in 18.2% of patients and was associated with a two-fold increase in the adjusted odds of 1-year mortality [2.29, 95% CI (1.32-3.97), P = 0.004]. In the subset of patients for whom periprocedural evidence of ischaemia was collected (n = 2316), Type 4a MI defined by the Fourth UDMI occurred in 12.7% of patients and was strongly associated with 1-year mortality [adj OR 3.21, 95% CI (1.42-7.27), P = 0.005]. We also present our results according to the type of troponin used (hs-cTn or conventional troponin).

conclusionOur analysis has demonstrated that in CCS patients with normal baseline cTn levels, the post-PCI cTn elevation of ≥5 × 99th percentile URL used to define Type 4a MI is associated with 1-year mortality and could be used to detect 'major' procedural myocardial injury in the absence of procedural complications or evidence of new myocardial ischaemia.

Indexed as

Coronary Artery DiseaseMyocardial InfarctionPercutaneous Coronary InterventionBiomarkersHumansTroponinBiomarkersTroponinElective PCIMyocardial infarctionMyocardial injuryProcedural complicationProcedural myocardial infarctionProcedural myocardial injury

Identifiers

PMID33257958
PMCPMC7850039
OpenAlexW3108176058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.